Electroporation of hPSCs

Hanqin Li, Oriol Busquets, Steven Poser, Dirk Hockemeyer, Frank Soldner

Published: 2022-09-07 DOI: 10.17504/protocols.io.b4phqvj6

Abstract

This protocol describes the standard procedure for the delivery of plasmids into human pluripotent stem cells (hPSCs) using electroporation.

Protocol Overview

A. Preparation of MEFs-cultured hPSCs for electroporation

B. Preparing plasmids for electroporation

C. Electroporation

General notes

  1. Throughout this protocol, the term hPSC is used to collectively refer to both hiPSCs and hESCs. All described procedures have been tested and work equally well for hiPSCs and hESCs.

Steps

A. Preparation of MEFs-cultured hPSCs for electroporation

1.

Incubate the hPSC cultures (on MEF feeders) in hPSC medium containing 10 µM Y-27632 (1:1000 dilution of stock) for at least two hours (overnight works as well) before electroporation. Two to three near confluent 6-well plates should provide sufficient cells for each individual experiment (higher than 10X106 hPSCs/experiment)

For a detailed protocol on hPSC cultures on MEF feeders, refer to the collection "Maintenance and inactivation of mouse embryonic fibroblasts (MEFs) as feeder cells for human pluripotent stem cell culture;" dx.doi.org/10.17504/protocols.io.b4pbqvin

1.1.

hPSCs medium

AB
DMEM/F12385 ml
Fetal Bovine Serum (FBS)75 ml
Knockout Serum Replacement25 ml
L-Glutamine (100X)5 ml
Penicillin & Streptomycin (100X)5 ml
MEM Non-Essential Amino Acids (100X)5 ml
2-Mercaptoethanol (10,000X)50 µl
Heat Stable Recombinant Human FGF2 (25µg/ml)*80 µl

*While we prefer Heat Stable Recombinant Human FGF2, we also have used regular FGF2. Final volume: 500ml

L-Glutamine (100X)

AB
L-Glutamine, powder14.6 g
MilliQ H2O500 ml

2-Mercaptoethanol (10,000X)

AB
2-Mercaptoethanol0.78 ml
MilliQ H2O9.22 ml

Heat Stable Recombinant Human FGF2 (25µg/ml)

AB
Heat Stable Recombinant Human FGF2500 µg
0.1% BSA20 ml

Final volume: 20ml

Y-27632 (1,000X)

AB
Y-276325 mg
DMSO1.56 ml

hPSCs medium + Rock inhibitor

AB
hPSCs medium500 ml
Y-27632 (1,000X)500 µl

Final volume: 500ml

2.

Wash the hPSC plates twice with DPBS

3.

Add 1 ml Trypsin/well of a 6-well plate and incubate for 0h 5m 0s at 37°C until colonies start detaching from MEF feeders.

4.

Add 2 ml hPSC medium to inactivate the trypsin.

5.

Collect single cell or small clump solution by trituration with P1000 pipette tips into 50 ml conical tube.

6.

Gravity precipitate cell solution for 0h 5m 0s min and remove large clumps of feeders with 5 ml pipette from the bottom of the conical tube.

7.

Centrifuge at225x g

8.

Remove the supernatant and re-suspend the cells at high concentration (higher than 10X106cells/700 µl) in ice-cold DPBS.

B. Preparing plasmids for electroporation

9.

Thaw plasmids On ice

10.

Dependent on the specific experiment (ZNFs-, TALEN- or CRISPR/Cas9-based genome editing) we recommend keeping the overall amount of plasmid DNA for each experiment below 50 µg.

11.

For CRISPR/Cas9 genome editing , use:

16 µg pX330-GFP gRNA (alternative: pX330-mcherry/BFP/YFP)

34 µg ssODN (single strand oligonucleotide containing modification, \~100 bp)
12.

For TALEN genome editing , use

7.5 µg for each (left and right) TALEN-nuclease plasmid

26 µg ssODN (single strand oligonucleotide containing modification, \~100 bp)

10 µg pEGFP-N1 (or comparable fluorescent protein expression vector)
13.

For ZFN genome editing , use

7.5 µg for each (left and right) ZFN-nuclease plasmid

26 µg ssODN (single strand oligonucleotide containing modification, \~100 bp)

10 µg pEGFP-N1 (or comparable fluorescent protein expression vector)
14.

For prime editing PE2 strategy, use

33 µg pCMV-PE2-GFP

12 µg pU6-pegRNA
15.

For prime editing PE3 strategy , use

33 µg pCMV-PE2-GFP

12 µg pU6-pegRNA

5 µg pBPK1520-ngRNA
16.

Pipet the proper amount of each plasmid into a micro centrifuge tube and keep On ice (4°C) until electroporation.

C. Electroporation

17.

Mix cell suspension (higher than 10X106cells/700 µl DPBS) with pre-made transfection solution (plasmid DNA), transfer in Biorad electroporation cuvette (4 mm) and incubate on ice for 0h 10m 0s

18.

Resuspend cell suspension cuvettes (either by careful vortexing or by hand) and pulse cuvettes using Biorad electroporator (Gene Pulser Xcell System, Bio-Rad: 250 V, 500 µF, 4 mm cuvettes).

19.

Carefully collect the cells and transfer to pre-warmed hPSC medium containing 10 µM Y-27632 (1:1000 dilution of stock) and distribute electroporated cell solution on an entire 6-well MEF feeder plate (DR4-MEFs for selection-based experiments and ICR-MEFs for subsequent FACS sorting)

20.

After plating shake the plate/s gently in the incubator and let it sit (37°C; 5% CO2; 5% O2).

21.

Refresh hPSC medium daily until FACS or drug selection (usually after 48 – 72 hours).

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询